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Objective This study aimed to establish interpretive criteria for agar diffusion tests with ceftibuten disks
according to DIN standards.
Methods Minimal inhibitory concentrations (MICs) and inhibition zones produced by ceftibuten in the disk
diffusion test were determined for 275 recent bacterial isolates, including 11 species with 25 strains each.
Regression analysis was performed for two disk loads (10 mg and 30 mg).
Results Correlation of MICs and zone diameters was good, with correlation coefﬁcients of r¼ 0.97
for both tested disk loads. Evaluation of the calculated zone size criteria for all species showed no very
major discrepancies or no major discrepancies. The 30-mg disks, however, produced unacceptably
large inhibition zones for very susceptible strains, so that usage of 10-mg disks must be recommended
when testing according to DIN standards.
Conclusion Based on the MIC breakpoints recommended by the DIN (8mg/L and 1mg/L), the
following interpretive breakpoints for disk diffusion susceptibility tests with 10-mg ceftibuten disks were
calculated using regression line analysis:19mm for resistance and 27mm for susceptiblity. Proposed
inhibition zone diameters for the reference strain Escherichia coli ATCC 25922 are between 31 and 36mm.
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INTRODUCTION
Ceftibuten is an orally administered cephalosporin that is stable
against plasmid-mediated b-lactamases [1,2], including
extended-spectrum b-lactamases [3]. It exhibits antimicrobial
activity against many Gram-negative and selected Gram-posi-
tive organisms. Clinical efﬁcacy has been demonstrated in the
treatment of upper and lower respiratory tract infections and
complicated and uncomplicated urinary tract infections. Com-
pared to older oral cephalosporin antibiotics, it has improved
pharmacokinetic properties. Ceftibuten is well absorbed (75–
90%) from the proximal gastrointestinal tract after oral admin-
istration [4,5]. Peak plasma levels (Cmax) after single oral doses of
200 and 400mg reached 9.9 and 17mg/L, respectively [6]. Its
half-life is 2.5 h in adults [4]. For several indications, ceftibuten
can be given once a day. Minimal inhibitory concentration
(MIC) breakpoints recommended by the DIN (German Insti-
tute for Standardization) [7] are 8mg/L for resistance and
1mg/L for susceptibility. This study aimed to establish appro-
priate interpretive criteria for susceptibility tests in ceftibuten by
using the disk diffusion method according to DIN 58 940.
MATERIALS AND METHODS
A total of 275 bacterial strains of Gram-positive and Gram-
negative bacteria, including 11 different species with 25 strains
each (Table 1), were included in the study. They were epide-
miologically unrelated recent clinical isolates from the Institute
for Medical Microbiology in Leipzig, Germany. Ceftibuten was
obtained from Essex Pharma GmbH (Mu¨nchen, Germany; Lot.
no. 8057). Iso-Sensitest media (Iso-Sensitest broth, Iso-Sensitest
agar, Oxoid, Basingstoke, UK) were used for both microbroth
dilution and disk diffusion tests.
For microbroth dilution assays, ceftibuten was dissolved in
0.1 M phosphate-buffered solution (pH8.0) according to the
manufacturer’s recommendations (Shionogi and Co. Ltd, Iwate,
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Japan). Appropriate dilutions of this stock solution were made
in Iso-Sensitest broth and dispensed into microdilution trays
(Greiner, D-72636 Frickenhausen, Germany), which were
stored until use at 80 8C.
Disk diffusion tests were performed according to DIN
58 940–3 [7]. Disks loaded with either 10 mg or 30 mg ceftibuten
were obtained from Mast Diagnostics (Merseyside, UK; 10 mg,
Lot No/Ch.-B 084390; 30 mg, Lot No/Ch.-B 081852) and
stored at 20 8C. Zones of inhibition were measured with
calipers after incubating for 18 2 h at 36 1 8C.
The correlations between zone diameters and MIC values
were determined by regression analysis according to the method
of least squares. In order to restrict the evaluation to the linear
portion of the parabolic regression curve, the regression statistic
was calculated using only isolates with MICs between 0.03 and
32mg/L.
To establish reference values for ceftibuten disk tests with the
reference strains recommended by DIN 58 940–3 [7], zone
diameters were determined for both disk loads using disks from
two different commercial manufacturers (Mast Diagnostics and
Becton Dickinson Co., Cockeysville, MD, USA; 10-mg, Lot.
1005 704638; 30 mg, Lot. 1006 804527). For Escherichia coli
ATCC 25922, a total of 40 readings for each disk load were
performed (ﬁve separate agar plates for each disk load, respec-
tively, were investigated on 4 successive days). Since all other
strains recommended by the DIN for quality control purposes
were resistant, 10 readings for each disk load were regarded as
sufﬁcient in these cases.
RESULTS
Table 1 shows the species-dependent distribution of ceftibuten
MIC values. These values do not reﬂect the present epidemio-
logical situation in Leipzig, since efforts were made to select
strains representing an even distribution of MICs over the range
of concentrations tested, in order to obtain a meaningful statistic
correlation. Among the Enterobacteriaceae, resistant strains with
MICs  8mg/L were only found for Enterobacter spp., Morga-
nella morganii, Serratia marcescens,Citrobacter freundii and Esch. coli.
For individual strains of Klebsiella pneumoniae, MICs ranged up
to 2mg/L, being just above the susceptibility threshold. Proteus
spp. were susceptible to 100% with a MIC90 of 0.06mg/L.
Altogether, median MICs for different species of the Entero-
bacteriaceae encompassed values from 0.03 to 2mg/L. All strains
of Acinetobacter baumanii were resistant to ceftibuten (MIC50
32 mg/mL). Figures 1 and 2 show the test results as scattergrams
comparing ceftibuten MICs with 10-mg and 30-mg ceftibuten
disk zone diameters, respectively. Table 2 presents the statistical
data of the regression analysis with 10-mg and 30-mg ceftibuten
disks. For both disk loads, MICs and zone diameters corre-
sponded to correlation coefﬁcients of r¼ 0.97. However,
there was a signiﬁcantly greater number of very large inhibitionTa
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zones (17.3% vs. 8.9% zones >40mm) produced by the 30-mg
disks than by the 10-mg disks. Based on the MIC breakpoints
recommended by DIN 58 940–4 [7] ( 1mg/L, 8mg/L),
10-mg disks and the calculated regression formula, the zone size
criteria are as follows: resistant 19mm, intermediate 20–
26mm and susceptible 27mm.
For the 10-mg disks there were no very major discrepancies,
no major discrepancies and 13 minor errors (5.1%). In spite of
the very good correlation, Serratia marcescens produced notice-
ably larger than average inhibition zones, contributing signiﬁ-
cantly to the error rate.
Table 3 shows the summarized results of the susceptibility
tests for the reference strain Esch. coli ATCC 25922. Clinically
signiﬁcant differences between disks produced by different
manufacturers were not noted. As expected, Pseudomonas aer-
uginosa ATCC 27853, as well as the Gram-positive reference
strains Staphylococcus aureus ATCC 29213, ATCC 25923 and
Ent. faecalis ATCC 29212 recommended by DIN 58 940–3 [7]
Figure1 Scattergram of ceftibuten broth microdilution MICs versus10-mg disk zone diameters on Iso-Sensitest agar using the DIN method.
Table2 Statistical data of regression analysisa and interpretive criteria for ceftibuten disks
Disk potency nb r Regression formula
Zone diameter (mm)
Susceptiblity Resistance
10-mg 243 0.97 x¼0.33 yþ18.12
y¼2.84þ53.10
27 19
30-mg 243 0.97 x¼0.37 yþ20.10
y¼2.54þ53.33
30 22
a Regression analysis for MIC range 0.03^32mg/L; b without extreme values; x¼MIC as the log2þ9; y¼ Zone diameter (mm).
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for quality control purposes, are resistant to ceftibuten and
consequently were not useful for quality control purposes.
DISCUSSION
A problem in the interpretation of bacterial susceptibility to
antimicrobial agents is the difference between national standards
by which these susceptibilities are determined, leading to
different interpretations for the same antibiotic in different
countries. According to the NCCLS, where the determination
of MIC breakpoints for ceftibuten is mainly based on peak
serum concentrations, the recommendations are  8mg/L for
susceptibility and 32mg/L for resistance[ 8]. The respective
values from the DIN are 1 mg/mL and 8 mg/mL, since
calculations are based to a greater extent on mean serum and
tissue concentrations [9].
For susceptibility tests of cephalosporins with the agar diffu-
sion method, disks with 30 mg potency are common interna-
tionally. However, some of the recently developed cephem
antibiotics, including ceftibuten, exhibit an increased antibac-
terial activity. Along with the comparably light inoculum of the
DIN method and the use of Iso-Sensitest media, the high
potency disks led to a great number of very large inhibition
zones. Correct reading of zone diameters of other antimicrobial
substances can be seriously disturbed when several disks with
large inhibition zones are used on one agar plate. For ceftibuten,
Figure2 Scattergram of ceftibuten brothmicrodilutionMICs versus 30-mg disk zone diameters on Iso-Sensitest agar using the DIN method.
Table3 Evaluation of susceptibility tests with ceftibuten disks for the reference strain Esch. coliATCC 25922
Organism Disk potency (lg) No. of replicate tests
Statistical data
of zone diameters
Median (mm)
MIC
SD Median (mg/L)
Esch. coliATCC 25922 10 40 34 0.65 0.25
30 40 37 0.72
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the correlation between MIC and zone diameter is very good
for both disk loads; however, the number of large inhibition
zones is signiﬁcantly lower for the 10-mg disks, rendering this
potency favorable for susceptibility testing. Disks with an even
lower potency are currently not readily available commercially
and therefore are not recommended here.
For quality control purposes of ceftibuten susceptibility tests,
only Esch. coli ATCC 25922 is well suited as a reference strain,
since the other strains recommended by DIN 58 940 result in
too small or no inhibition zone diameters. MICs for Esch. coli
ATCC 25922 should range between 0.125 and 0.5mg/L. The
MIC values obtained in our studies are in good agreement with
the values established previously by Jones and Barry [1]. We
concluded from the replicate disk diffusion tests performed with
the Esch. coli reference strain that the corresponding inhibition
zone diameters achieved with DIN 58 940 should be in the
range of 34 3mm.
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